Clinical trial Recruiting at 1 site Observational Ages 18 and up

Respiratory Physiotherapy in Critically Ill Pneumonia Patients

Official title: Dynamics of Procalcitonin and C-Reactive Protein Associated With Respiratory Physiotherapy in Critically Ill Patients With Pneumonia

Run by Hospital H+ Queretaro · NCT07909616 · Data updated 2026-11-12

This study tests whether a structured breathing and chest therapy program can change inflammatory biomarkers in adults with pneumonia in the ICU compared to usual care.

More Pneumonia trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment180 (estimated)
SponsorHospital H+ Queretaro
Academic / other
Locations1 site (Querétaro)
StatusRecruiting
StartedSeptember 8, 2026
Main results expectedNovember 30, 2026
Study endsDecember 1, 2026
Registry record updatedNovember 2, 2026
Trial IDNCT07909616 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with confirmed pneumonia admitted to the ICU and an anticipated or actual ICU stay of at least 48 hours.

Probably not a fit

Patients without pneumonia or those with conditions that alter the inflammatory biomarkers or prevent safe physiotherapy may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study follows adults with pneumonia in the ICU to see if a protocolized respiratory physiotherapy program affects levels of inflammatory biomarkers like procalcitonin and CRP. It compares patients receiving structured physiotherapy to a historical control group receiving standard care, focusing on biomarker trajectories and ICU length of stay. Safety of the physiotherapy sessions is also monitored, including events such as desaturation or hemodynamic changes. The analysis will describe changes over time and potential associations with clinical outcomes.

Why it matters

Potential benefit: If successful, the protocolized physiotherapy could help reduce systemic inflammation and possibly shorten ICU stays for pneumonia patients.

How similar studies have gone: Prior studies have explored physiotherapy in critical illness, with mixed results; this study adds a biomarker trajectory focus using a historical control.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Consecutive adult patients (age \>= 18 years at the time of admission).
* Confirmed diagnosis of pneumonia (community-acquired, hospital-acquired, or ventilator-associated pneumonia) as the primary cause of ICU admission or critical complication.
* Anticipated or actual ICU length of stay \>= 48 hours.

Exclusion Criteria:

* Presence of limitation of medical treatment orders or exclusively palliative management upon admission.
* Concomitant severe non-infectious systemic inflammatory diseases that massively alter or mask procalcitonin response (e.g., severe acute pancreatitis, extensive burns).
* Refractory hemodynamic instability or uncontrolled septic shock with escalating vasopressor requirements that contraindicate physical manipulation.

Where it's running

  • Hospital H+ Querétaro, Santiago de Querétaro, Querétaro
    Querétaro, Mexico
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.